Navigation Links
Hospira Announces Further Extension of Tender Offer for Shares of Javelin Pharmaceuticals
Date:6/3/2010

LAKE FOREST, Ill., June 3 /PRNewswire-FirstCall/ -- Hospira, Inc. (NYSE: HSP), a global specialty pharmaceutical and medication delivery company, today announced a further extension of the tender offer by Discus Acquisition Corporation, a wholly owned Hospira subsidiary, to purchase all outstanding shares of the common stock of Javelin Pharmaceuticals, Inc. (NYSE - Amex: JAV).

As reported by Javelin on May 24, 2010, Therabel Pharma UK Limited ("Therabel"), a subsidiary of Therabel Pharma N.V. and Javelin's licensee of commercial rights to Dyloject™ (diclofenac sodium) in the European Union, has informed Javelin and publicly announced that it is withdrawing all batches of Dyloject (diclofenac 75mg/2ml) from the UK market with a Drug Alert Class 2 Medicines Recall. Therabel reported that it became aware of the presence of a white particulate matter in some vials of Dyloject in its supply chain.

Since being advised of the particulate issue affecting Javelin's Dyloject product, Hospira's scientific and regulatory teams have worked with their counterparts at Javelin to conduct an initial analysis of the cause of the issue and to begin to assess its probable effect on Javelin's business. Based on its evaluation of the information regarding the particulate issue that have been made available to date, and in accordance with the merger agreement between the parties, Hospira has delivered notice of the extension of the tender offer to Javelin based on its determination that all of the conditions to the offer had not been satisfied as of the expiration date of the offer. Hospira intends to continue to work with Javelin to confirm the satisfaction of the conditions to the offer as promptly as p
'/>"/>

SOURCE Hospira, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. Hospira Acquires Worldwide Rights to Biogeneric Version of Filgrastim
2. Hospira Acquires Worldwide Rights to Biogeneric Version of Filgrastim and Manufacturing Facility From PLIVA
3. Hospira, Celltrion, Enter Business Cooperation Agreement to Develop and Market Biogeneric Drugs
4. Hospira to Present at Credit Suisse 18th Annual Healthcare Conference Nov. 11
5. Hospira Names Daphne E. Jones Chief Information Officer
6. Hospira Reports Third-Quarter 2009 Results
7. Hospira Supports Disaster Relief Efforts in Haiti With Products and Cash Grants
8. Hospira to Present at J.P. Morgan 28th Annual Healthcare Conference Jan. 13, 2010
9. Hospira to Host Conference Call for Fourth-Quarter 2009 Results and 2010 Projections
10. Hospira Acquires TheraDoc, Enhances Medication Safety and Infection Management Offerings
11. Hospira Expands VisIV(TM) Portfolio to Offer Complete Range of Environmentally Friendly I.V. Containers
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/22/2014)... -- Research and Markets has announced the ... Industry Report 2014" report to their offering. ... Report 2014 is a professional and in-depth study on ... with a focus on the Chinese situation. The ... definitions, classifications, applications and industry chain structure. The particulate ...
(Date:8/22/2014)... ., Aug. 22, 2014  Research presented at the 29 ... being developed by Hera Therapeutics Inc. combats three types of ... all cervical cancer. When tested in several cultured ... and HPV-11 cells, according to Louise T. Chow , ... findings at the Seattle conference. The ...
(Date:8/22/2014)... 22, 2014  Mark Riccio, director of Cornell ... is using the online crowd-funding platform Kickstarter to ... to researchers and would-be superheros everywhere: "for FREE." ... YOU do if you had Superman,s X-ray vision?" ... explorers everywhere, from elementary through high school students, ...
Breaking Medicine Technology:Global and Chinese Particulate Respirators Industry Report 2014 2Study shows Hera Therapeutics experimental compound shuts down human papillomavirus that causes most cervical cancer 2Cornell's X-ray Imaging Lab Director Uses Kickstarter Campaign to "Democratize" Advanced 3D Imaging 2
... Calif., Nov. 10, 2010 ChemoCentryx, Inc., today ... the Annual American College of Rheumatology Meeting (ACR). ... is designed to target the receptor for the ... so-called anaphylatoxin that drives inflammatory responses associated with ...
... BLOOMINGTON, Minn., Nov. 10, 2010 A new ... Improvement (ICSI, www.icsi.org ), a nonprofit, health ... care community more than $28 million annually, as ... productivity. The initiative is the first ...
Cached Medicine Technology:ChemoCentryx Reports Positive Phase I Results for CCX168, a Novel C5aR Antagonist, at the Annual American College of Rheumatology Meeting (ACR) 2ChemoCentryx Reports Positive Phase I Results for CCX168, a Novel C5aR Antagonist, at the Annual American College of Rheumatology Meeting (ACR) 3ChemoCentryx Reports Positive Phase I Results for CCX168, a Novel C5aR Antagonist, at the Annual American College of Rheumatology Meeting (ACR) 4Statewide Initiative Launched to Help Ensure Patients Receive Appropriate High-Tech Diagnostic Imaging Exams 2Statewide Initiative Launched to Help Ensure Patients Receive Appropriate High-Tech Diagnostic Imaging Exams 3Statewide Initiative Launched to Help Ensure Patients Receive Appropriate High-Tech Diagnostic Imaging Exams 4Statewide Initiative Launched to Help Ensure Patients Receive Appropriate High-Tech Diagnostic Imaging Exams 5
(Date:8/22/2014)... “Dr. Luciana Show – Aging and Falling” is ... is finding it challenging to stay on top of post-production ... hundreds of students, so the editing of the episodes will ... and she recently entered it into the festival circuit. ... husband, actor/screenwriter Gregory Graham , the aging and falling ...
(Date:8/22/2014)... Oncology (ESMO), the leading pan-European organisation representing medical ... outstanding individuals receiving the Society,s esteemed annual awards. ... Heikki Joensuu and Peter Boyle on the occasion ... Spain. , Carsten Bokemeyer will receive the ESMO ... of cancer discovery into real benefit at patient ...
(Date:8/22/2014)... Chest pain, breathing difficulties, fainting. Each year approx. 265,000 ... of serious illness. New research from Aarhus University and ... as many as every fourth patient are ... severe symptoms that led to the acute hospitalisation., "Naturally, ... examinations at the hospital disprove that there is a ...
(Date:8/22/2014)... can be slowed and some of its symptoms ... in pomegranate. Also, the painful inflammation that ... disease could be reduced, according to the findings ... Huddersfield scientist Dr Olumayokun Olajide, who specialises in ... a new phase of research can explore the ...
(Date:8/22/2014)... treated for the cancer Hodgkin lymphoma will be able ... researchers estimated their risk of premature menopause with different ... Journal of the National Cancer Institute , are based ... in England and Wales treated for the cancer over ... research has suggested that women with Hodgkin lymphoma who ...
Breaking Medicine News(10 mins):Health News:Professor Luciana Lagana Dedicates to Her CSUN Students the “Dr. Luciana Show-Aging and Falling” AOF Festival Nomination (Screening at Krikorian Monrovia Cinema on 08/25) 2Health News:Professor Luciana Lagana Dedicates to Her CSUN Students the “Dr. Luciana Show-Aging and Falling” AOF Festival Nomination (Screening at Krikorian Monrovia Cinema on 08/25) 3Health News:Professor Luciana Lagana Dedicates to Her CSUN Students the “Dr. Luciana Show-Aging and Falling” AOF Festival Nomination (Screening at Krikorian Monrovia Cinema on 08/25) 4Health News:ESMO honors outstanding oncology professionals 2Health News:ESMO honors outstanding oncology professionals 3Health News:Many patients are discharged without a diagnosis 2Health News:Research underway to create pomegranate drug to stem Alzheimer's and Parkinson's 2Health News:Scientists map risk of premature menopause after cancer treatment 2
... Elsevier , the world-leading publisher of scientific, technical ... Silverstein whose new book, The Initial Psychotherapy ... Award from the American Psychological Association,s Society for ... Transgender Issues. Dr. Silverstein also received a Gold ...
... Reporter , WEDNESDAY, Aug. 24 (HealthDay News) -- The percentage ... 14 percent from 22 percent in 2008, a new survey ... the September issue of Obstetrics & Gynecology , don,t ... according to those on both sides of the abortion debate. ...
... Gordon HealthDay Reporter , WEDNESDAY, Aug. ... of the antibiotic azithromycin may help prevent life-threatening ... say. These complications are commonly referred to ... doctor visits and hospitalizations. Although numerous medications are ...
... , THURSDAY, Aug. 25 (HealthDay News) -- Rheumatoid ... physical activity goals -- called self-efficacy -- are more ... The investigators also found that patients who achieve their ... and a higher quality of life. Researchers in ...
... report that patients with rheumatoid arthritis (RA) who have ... likely to achieve their physical activity goals. According to ... Research , a journal of the American College of ... with lower self-reported arthritis pain and increased health-related quality ...
... million grant from the John D. and Catherine T. ... Research Network on Law and Neuroscience. The MacArthur ... effects of modern neuroscience on criminal law and trying ... The network will be led by Vanderbilt professor Owen ...
Cached Medicine News:Health News:Elsevier congratulates Dr. Charles Silverstein upon his receipt of 2 awards 2Health News:Only 1 in 7 Ob/Gyns Now Performs Abortions, Survey Finds 2Health News:Only 1 in 7 Ob/Gyns Now Performs Abortions, Survey Finds 3Health News:Long-Term Antibiotic Use May Lessen COPD Flare-Ups 2Health News:Long-Term Antibiotic Use May Lessen COPD Flare-Ups 3Health News:Achieving realistic physical activity goals benefits RA patients 2Health News:Landmark law and neuroscience network expands at Vanderbilt 2Health News:Landmark law and neuroscience network expands at Vanderbilt 3
... Keeler Galilean loupes are ideal ... when increased magnification and a large ... loupes are laser aligned, lightweight and ... ,Fixed working distance and superior depth ...
U tip irrigation-aspiration cannual designed for manual removal of 12 oclock cortex. 23 gauge thin wall irrigation and aspiration lines for maximum aspiration capabilities. Polished finish. Overall l...
... stools come with five legs for ... 18" to 25" (total vertical travel ... rubber castors. Comfortable, durable and fire ... as standard, other colors available by ...
Anterior Stromal Puncture Cannula, 25 g. For treatment of recurrent corneal erosion. Overall length 24 mm. 5/box....
Medicine Products: